vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Koppers Holdings Inc. (KOP). Click either name above to swap in a different company.
Koppers Holdings Inc. is the larger business by last-quarter revenue ($432.7M vs $270.8M, roughly 1.6× HUTCHMED (China) Ltd). Koppers Holdings Inc. runs the higher net margin — 6.9% vs 0.7%, a 6.1% gap on every dollar of revenue. On growth, Koppers Holdings Inc. posted the faster year-over-year revenue change (-9.3% vs -16.5%). Koppers Holdings Inc. produced more free cash flow last quarter ($28.5M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Koppers is a global chemical and materials company based in Pittsburgh, Pennsylvania, United States. Its headquarters is an art-deco 1920s skyscraper, the Koppers Tower.
HCM vs KOP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $432.7M |
| Net Profit | $2.0M | $29.7M |
| Gross Margin | 37.7% | 25.6% |
| Operating Margin | -13.2% | 11.5% |
| Net Margin | 0.7% | 6.9% |
| Revenue YoY | -16.5% | -9.3% |
| Net Profit YoY | -83.6% | 391.2% |
| EPS (diluted) | $0.00 | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $432.7M | ||
| Q3 25 | — | $485.3M | ||
| Q2 25 | $277.7M | $504.8M | ||
| Q1 25 | $324.5M | $456.5M | ||
| Q4 24 | — | $477.0M | ||
| Q3 24 | — | $554.3M | ||
| Q2 24 | $305.7M | $563.2M | ||
| Q1 24 | — | $497.6M |
| Q4 25 | $2.0M | $29.7M | ||
| Q3 25 | — | $23.8M | ||
| Q2 25 | $455.0M | $16.4M | ||
| Q1 25 | $11.9M | $-13.9M | ||
| Q4 24 | — | $-10.2M | ||
| Q3 24 | — | $22.8M | ||
| Q2 24 | $25.8M | $26.8M | ||
| Q1 24 | — | $13.0M |
| Q4 25 | 37.7% | 25.6% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | 0.1% | 22.6% | ||
| Q1 25 | 48.0% | 23.2% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | — | 21.9% | ||
| Q2 24 | 41.1% | 21.6% | ||
| Q1 24 | — | 19.3% |
| Q4 25 | -13.2% | 11.5% | ||
| Q3 25 | — | 10.7% | ||
| Q2 25 | -1.3% | 7.7% | ||
| Q1 25 | -5.0% | 5.9% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 9.0% | ||
| Q2 24 | -9.0% | 10.2% | ||
| Q1 24 | — | 7.0% |
| Q4 25 | 0.7% | 6.9% | ||
| Q3 25 | — | 4.9% | ||
| Q2 25 | 163.8% | 3.2% | ||
| Q1 25 | 3.7% | -3.0% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | 8.4% | 4.8% | ||
| Q1 24 | — | 2.6% |
| Q4 25 | $0.00 | $1.44 | ||
| Q3 25 | — | $1.17 | ||
| Q2 25 | $0.52 | $0.81 | ||
| Q1 25 | $0.01 | $-0.68 | ||
| Q4 24 | — | $-0.47 | ||
| Q3 24 | — | $1.09 | ||
| Q2 24 | $0.03 | $1.25 | ||
| Q1 24 | — | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | — |
| Total DebtLower is stronger | $93.2M | $928.3M |
| Stockholders' EquityBook value | $1.2B | $574.0M |
| Total Assets | $1.8B | $1.9B |
| Debt / EquityLower = less leverage | 0.08× | 1.62× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $836.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $802.5M | — | ||
| Q1 24 | — | — |
| Q4 25 | $93.2M | $928.3M | ||
| Q3 25 | — | $932.9M | ||
| Q2 25 | $93.4M | $977.5M | ||
| Q1 25 | $82.8M | $989.0M | ||
| Q4 24 | — | $939.5M | ||
| Q3 24 | — | $989.4M | ||
| Q2 24 | $82.1M | $1.0B | ||
| Q1 24 | — | $877.6M |
| Q4 25 | $1.2B | $574.0M | ||
| Q3 25 | — | $545.6M | ||
| Q2 25 | $1.2B | $526.8M | ||
| Q1 25 | $759.9M | $498.0M | ||
| Q4 24 | — | $488.7M | ||
| Q3 24 | — | $532.3M | ||
| Q2 24 | $740.1M | $509.2M | ||
| Q1 24 | — | $505.8M |
| Q4 25 | $1.8B | $1.9B | ||
| Q3 25 | — | $1.9B | ||
| Q2 25 | $1.8B | $1.9B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $1.3B | $1.9B | ||
| Q1 24 | — | $1.8B |
| Q4 25 | 0.08× | 1.62× | ||
| Q3 25 | — | 1.71× | ||
| Q2 25 | 0.08× | 1.86× | ||
| Q1 25 | 0.11× | 1.99× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | 0.11× | 1.97× | ||
| Q1 24 | — | 1.74× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $45.1M |
| Free Cash FlowOCF − Capex | $3.4M | $28.5M |
| FCF MarginFCF / Revenue | 1.2% | 6.6% |
| Capex IntensityCapex / Revenue | 1.8% | 3.8% |
| Cash ConversionOCF / Net Profit | 4.21× | 1.52× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $67.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $45.1M | ||
| Q3 25 | — | $49.6M | ||
| Q2 25 | $-72.9M | $50.5M | ||
| Q1 25 | $40.3M | $-22.7M | ||
| Q4 24 | — | $74.7M | ||
| Q3 24 | — | $29.8M | ||
| Q2 24 | $-39.8M | $27.2M | ||
| Q1 24 | — | $-12.3M |
| Q4 25 | $3.4M | $28.5M | ||
| Q3 25 | — | $37.6M | ||
| Q2 25 | $-82.2M | $38.4M | ||
| Q1 25 | $32.5M | $-37.0M | ||
| Q4 24 | — | $56.1M | ||
| Q3 24 | — | $14.4M | ||
| Q2 24 | $-49.9M | $10.1M | ||
| Q1 24 | — | $-38.6M |
| Q4 25 | 1.2% | 6.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | -29.6% | 7.6% | ||
| Q1 25 | 10.0% | -8.1% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | — | 2.6% | ||
| Q2 24 | -16.3% | 1.8% | ||
| Q1 24 | — | -7.8% |
| Q4 25 | 1.8% | 3.8% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | 3.3% | 2.4% | ||
| Q1 25 | 2.4% | 3.1% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | 3.3% | 3.0% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | 4.21× | 1.52× | ||
| Q3 25 | — | 2.08× | ||
| Q2 25 | -0.16× | 3.08× | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.31× | ||
| Q2 24 | -1.54× | 1.01× | ||
| Q1 24 | — | -0.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
